HOME >> BIOLOGY >> NEWS
Honey as healer

Ancient healer effective in treating infected skin lesions

Jem Bonnievale was 15 when he contracted meningococcal septicemia caused by an infection of Neisseria meningitidis. By the time the British teenager reached the hospital, he had multiple purple batches on his legs and fingers, which rapidly progressed to tissue death. Both legs were amputated below the knee as well as fingers on both hands. He endured multiple skin grafts and suffered for months with non-healing infected sores. His case was extreme and difficult to treat because of the severe pain it caused. "I can't even begin to explain how painful it was just to have a small piece of dressing changed. The nurses tried everything to make it easier, like changing the dressing in the bath, but it was agony," said Jem. Over the next six months the success of the grafts was variable and the sores showed heavy growth of Pseudomonas and Staphlococcus aureus. All traditional treatments were tried without success.

When nothing else had any effect on the chronic infected sores, clinical nurse Cheryl Dunford and her colleagues turned to honey. Dressing pads impregnated with sterilized active manuka honey from New Zealand were applied to one leg and a traditional dressing to the other leg. Within a few days, the honey dressed leg showed a reduction of wound bacteria. Both legs were then treated with the honey dressings. Within 10 weeks, all lesions were healed. Jem was released from the hospital, fitted with artificial legs and is getting on with his life.

The use of honey as medicine is mentioned in the most ancient written records. Today scientists and doctors are rediscovering the effectiveness of honey as a wound treatment. Dr. Peter Molan, Professor of Biochemisty at Waikato University, New Zealand has been on the forefront of honey research for 20 years. He heads the university's Honey Research Unit, which is internationally recognized for its expertise in the a
'"/>

Contact: Mary Ann Johnson
mjohnson@zfpartners.com
415-268-5421
Zuckerman Fernandes & Partners
31-Jul-2000


Page: 1 2

Related biology news :

1. Honey bee genome assembled
2. Honeybee gene find ends 150-year search
3. Honey bee genome being sequenced
4. Honey the darker the better Has potential as dietary antioxidant
5. USDA establishes Honeybee Genetics and IPM Center
6. Honey shines in athletic research, has scientific community abuzz
7. Honey : Naturess sweetener may increase recuperation after workouts
8. Honey may be the ideal pre-workout energy source
9. Honey in the medicine cabinet!
10. Dark Honey Has More Illness-Fighting Agents Than Light Honey
11. Summer Science: Where Have All The Honeybees Gone? UD Bee Guy Asks Why--From America To The Amazon

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Honey healer

(Date:11/21/2014)... 2014 C-Labs LLC, a leading provider of ... (IoT), today announced the appointment of John Traynor ... a strategic advisor to the firm, Mr. Traynor will ... is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. Photo ...
(Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
(Date:11/15/2014)... 13, 2014  While we may still be a few ... in "Star Trek" to gain instant access to all that ... with smartphones and tablets for monitoring and measuring our health ... This may seem a tad Orwellian to some, but a ... of these technological opportunities into their healthcare regime. ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
(Date:12/17/2014)... Based on the revenues gained from ... is dominated by four major players contributing to ... players include GE Healthcare (U.K.), Siemens AG (Germany), ... Full Report Copy at http://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html , ... attributed to its strong product portfolio, which includes ...
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Xeno ... Excellence following its most recent COLA inspection. Xeno ... COLA, a national healthcare accreditation organization. Accreditation is ... of quality in day-to-day operations, demonstrate continued accuracy ... a rigorous on-site laboratory survey. , ...
(Date:12/17/2014)... Texas , Dec. 16, 2014  Vermillion, Inc. ... focused on gynecologic disease, today announced the next step ... a premier bio-analytics solutions provider with the naming of ... President and Chief Executive Officer, while current Chairman of ... continue to serve as Chairman. These changes are effective ...
Breaking Biology Technology:Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4
Cached News: